ASD-255

N/A

Report date: 2023/04/23 16:11:40

Base Information

Drug NameASD-255
Drug Alias NameASD-255
ClassificationVaccines
Mechanisms of ActionTryptophan 2,3-dioxygenase modulatorsImmunomodulators
TargetsTryptophan 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAscendo Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A